The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Nanotechnology for Omics-Based Ocular Drug Delivery
|
Author(s): Anjali Hirani (University of South Florida, USA & Virginia Tech-Wake Forest University, USA), Aditya Grover (University of South Florida, USA), Yong Woo Lee (Virginia Tech-Wake Forest University, USA), Yashwant Pathak (University of South Florida, USA)and Vijaykumar Sutariya (University of South Florida, USA)
Copyright: 2015
Pages: 15
Source title:
Handbook of Research on Diverse Applications of Nanotechnology in Biomedicine, Chemistry, and Engineering
Source Author(s)/Editor(s): Shivani Soni (Alabama State University, USA), Amandeep Salhotra (City of Hope National Medical Center, USA)and Mrutyunjay Suar (KIIT University, India)
DOI: 10.4018/978-1-4666-6363-3.ch008
Purchase
|
Abstract
Millions of people suffer from ocular diseases that impair vision and can lead to blindness. Advances in genomics and proteomics have revealed a number of different molecular markers specific for different ocular diseases, thereby optimizing the processes of drug development and discovery. Nanotechnology can increase the throughput of data obtained in omics-based studies and allows for more sensitive diagnostic techniques as more efficient drug delivery systems. Biocompatible and biodegradable nanomaterials developed through omics-based research are able to target reported molecular markers for different ocular diseases and offer novel alternatives to conventional drug therapy. In this chapter, the authors review the pathophysiology, current genomic and proteomic information, and current nanomaterial-based therapies of four ocular diseases: glaucoma, uveal melanoma, age-related macular degeneration, and diabetic retinopathy. Omics-based research can be used to elucidate specific genes and proteins and develop novel nanomedicine formulations to prevent, halt, or cure ocular diseases at the transcriptional or translational level.
Related Content
Wassim Jaber.
© 2024.
24 pages.
|
Hussein A.H. Jaber, Zahraa Saleh, Wassim Jaber, Adnan Badran, Hatem Nasser.
© 2024.
17 pages.
|
Sakshi Garg, Kunal Arora, Sumita Singh, K. Nagarajan.
© 2024.
20 pages.
|
Wassim Jaber.
© 2024.
14 pages.
|
Ray Gutierrez Jr..
© 2024.
22 pages.
|
Wassim Jaber, Hussein A.H. Jaber, Ramzi Jaber, Zahraa Saleh.
© 2024.
16 pages.
|
Zahraa Saleh, Wassim Jaber, Ali Jaber, Edmond Cheble, Mikhael Bechelany, Akram Hijazi, David Cornu, Ghassan Mahmoud Ibrahim.
© 2024.
22 pages.
|
|
|